Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs Ivim Health

boostAGErx
Graded #201

Higher grade

vs+6.499999999999993
Ivim Health
Graded #338

Lower grade

The verdict

boostAGErx takes it — 66.1/100 to 59.6/100.

boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth service selling compounded GLP-1 weight management alongside peptide therapy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +30
74
44
Dose & formulationEven
64
64
Clinical oversightIvim Health +5
74
79
Labs & monitoringEven
52
52
FulfillmentboostAGErx +20
85
65
Contract termsIvim Health +30
25
55
boostAGErx · left barIvim Health · right bar

The numbers

MetricboostAGErxIvim Health
WeighScore66.1/10059.6/100
GradeCC
Scorecard rank#201#338
Semaglutide$95/mo (billed every 28 days, compounded)$149/mo (starting dose, medication and programme fee, compounded)
Tirzepatide$145/mo (billed every 28 days, compounded)$224/mo (starting dose, medication and programme fee, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #201 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
  • The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
  • Prices are rendered entirely in JavaScript; the page's HTML body is empty, so nothing is readable without running the bundle
  • Shipped compounded medication is non-refundable
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Ivim Health

Graded #338 · C

Strengths

  • Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
  • A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
  • The first month of the membership is free

Where it loses points

  • A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
  • The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
  • Both figures are 'starting at' rates, so the cost of a titrated dose is not published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard